Status: Recruiting
The Effects of ECMO on the Pharmacokinetics of Hydromorphone
The purpose of this study was to establish a population pharmacokinetic (PPK) model of hydromorphone in patients under ECMO, and to recommend a dosing regimen when the target effective concentration was reached.
Participants needed: 26
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Xiaobo Yang, MDUpdated: Aug 6, 2024Locations: 1
Eligibility criteria
Between the ages of 18 and 80; [+2]
Allergic to hydromorphone; [+5]